Webinar: Early Stage Treatment Options

Описание: November 2020 - Living with cutaneous lymphoma and understanding the treatment options available can be overwhelming. The good news is that there are many treatments available today. Drs. Steven Horwitz and Sarah Noor from Memorial Sloan Kettering Cancer Center share an overview of current treatment options for early stage cutaneous lymphoma and new treatments in the pipeline. (Click "See More" for questions and timestamps)

Q&A Timestamps
00:09:01 When you see a patient with a subtle presentation of MF, what type of things do you think about when working them up?

00:13:14 Do you have a rule of thumb for how long a patient should be off topical steroids before a skin biopsy, and does it have to be all spots, or just some spots?

00:14:42 Are there some cases where you can't make a diagnosis after one or more biopsies, and what do you after that?

00:16:35 In a patient with early MF, what other tests (blood work or imaging) do you perform, and in what cases?

00:21:40 When you say "skin thinning", what exactly does that mean, and is it ever dangerous?

00:31:15 Is there an amount of skin involvement determines what type of topical treatment you use, and do you have patients only put them on the areas involved, or in broader areas?

00:33:03 If someone has extensive disease, what treatments do you look at?

00:38:56 What would be your treatment approach for a patient with early stage MF and mostly plaques?

00:42:08 Is your treatment approach to early stage MF changed if there are abnormal blood tests?

00:44:42 When would you use a genetic screen to predict T-cell lymphoma aggression?

00:45:44 Assuming only skin involvement, how do you determine that remission has been achieved?

00:47:14 How is erythrodermic MF/Sezary syndrome determined, especially related to the eyelids?

00:48:59 I was diagnosed via biopsy with a lone tumor without other symptoms and treated with topical steroids. Should I anticipate the development of other skin lesions and plaques?

00:49:54 I was diagnosed with stage 1a MF and had UVB therapy for 6 months, causing the patches to disappear. What are the chances of them reappearing, and if one was 1a, what percent of patients progress to more involvement?

00:51:07 Are topical and other treatment options for lymphomatoid papulosis the same as MF?

00:52:01 For topical steroids, does it matter if it is applied once or twice daily? If the patch is showing good results, is once a day enough?

00:52:32 Is there a need for treatment if the rashes, plaques or tumors are not bothering the patient, other than being unsightly?

00:53:39 What about triamcinolone .01%?

00:54:38 I have had an intensive course of light therapy alternating between nbUVB every other week and 3 times a week in the lightbox due to recurrences. Am I at an increased risk for other skin cancers?

00:55:57 What are your thoughts on a "wait and see" approach? (stage 1b CD8+ MF with hypopigmented patches and small red slightly raised patches with no itching, nbUVB not well tolerated)

00:57:58 What should I look for in blood results in the early stage?

00:58:20 What is the max dose of nbUVB?